SlideShare a Scribd company logo
1 of 1
21
BackgroundAbstract
Secretoglobin (SCGB) 3A2, formerly called
Uteroglobin-related protein (UGRP) 1, was
originally identified as a downstream target for a
homeodomain transcription factor, NKX2-1.
SCGB3A2 is highly expressed in the epithelial
cells of the trachea, bronchus and bronchioles.
SCGB3A2 exhibits anti-inflammatory and anti-
fibrotic functions as well as growth factor
activity that is responsible for fetal lung
development. Our recent study demonstrated
that SCGB3A2 is over-expressed in lung
carcinomas, particularly adenocarcinomas in
humans. In order to further understand the
physiological roles of SCGB3A2 in lungs and/or
lung diseases including lung cancer, we have
produced Scgb3a2 knockout mice. These
knockout mice are characterized to identify
additional roles for SCGB3A2 in lungs. Our
purpose of this study is to understand the
biological function and molecular mechanism of
SCGB3A2 in a mouse model of oncogenic K-ras-
induced lung cancer.
Ccsp-Cre/LSL-K-rasG12D knock-in mouse
mated with floxed Scgb3a2 mouse
Compare the phenotypes of Scgb3a2 (+/flox)
to Scgb3a2 (flox/flox) in oncogenic K-ras mice
Future Experiments
• To obtain pathological analysis for
the classification of cancer severity.
• To extend the observational time in
order to obtain a more accurate
survival curve and increase the
sample size of +/fl and fl/fl mice for
lung weight data.
• Prepare mouse embryonic (MEF) and
primary lung fibroblasts from mice
carrying K-rasG12D in the
background of Scgb3a2(-/-) or wild
type, and treat them with
recombinant adenovirus expressing
Cre recombinase (Ad-Cre) to study
the mechanism for the role of
SCGB3A2 in carcinogenesis.
Summary
• Floxed, transgenic and knock-in alleles
were identified by PCR.
• Oncogenic K-ras induced lung cancers
were developed in Scgb3a2 (+/flox),
Scgb3a2 (flox/flox) and wild type mice.
• Scgb3a2 (flox/flox) displays a
shortened life span compared with
Scgb3a2 (+/flox) in oncogenic K-ras-
induced lung carcinogenesis.
• Gross tumor number, body weight,
tumor size, and lung weight had no
significant difference between
Scgb3a2 (+/flox) and Scgb3a2
(flox/flox) mice.
• SCGB3A2 might inhibit oncogenic K-
ras-induced lung carcinogenesis.
Genotype PCR
650
400
200
WT +/f f/f
300
500
WT (411 bp)
Floxed (354 bp)
- - + +
550 bp
400
500
650
850
1000
408 bp
400
500
300
- - + +
Floxed Scgb3a2
Ccsp-Cre
K-ras G12D (Oncogenic K-ras)
LSL-K-rasG12D
knock-in allele
Floxed Scgb3a2X
WT K-ras allele
Activated K-rasG12D
allele
Ccsp-Cre;LSL-K-ras G12D
Effect of the loss of SCGB3A2 on oncogenic K-ras-induced lung
carcinogenesis in mice
Angela Zhou, Mitsuhiro Yoneda, Jorge Paiz, and Shioko Kimura
Endocrinology Section, Laboratory of Metabolism, Center for Cancer Research, NCI, NIH, Bethesda, MD 20892, USA
SCGB3A2 suppresses K-ras-induced carcinogenesis in
mice lungs.
Ccsp-Cre;LSL-K-ras
G12D;Scgb3a2
single floxed (+/f)
Ccsp-Cre;LSL-K-ras
G12D;Scgb3a2
double floxed (f/f)
Expected incidence of
lung cancer
Hypothesis
Mice
Ccsp-Cre;LSL-K-rasG12D;Scgb3a2(f/f) and Ccsp-
Cre;LSL-K-rasG12D;Scgb3a2(+/f) mice are used in
this study. Ccsp-Cre/LSL-K-rasG12D conditional
mutant mice were kindly provided from Dr. DeMayo
(Baylor College of Medicine). Floxed-Scgb3a2 mice
were produced in our laboratory. All mice were
maintained under standard specific-pathogen-free
conditions. All experiments were carried out
following guidelines for animal use issued by the
National Institutes of Health and approved by the
National Cancer Institute (NCI) Animal Care and Use
Committee.
Genotyping for conditional mutant mice
Floxed, transgenic and knock-in mice were identified
using PCR primers specific for each transgene.
Amplification of PCR products for floxed and Cre
transgenic mice were performed as follows:
•Denaturation at 94°C for 5 min
•38 cycles of:
•Denaturation at 94°C for 15 sec
•Annealing at 60°C for 30 sec
•Extension at 72°C for 15 sec
•5-min extension at 72°C
Amplification for the LSL-K-rasG12D knock-in allele
was performed as follows:
•Denaturation at 94°C for 3 min
•40 cycles of:
•Denaturation at 94°C for 30 sec
•Annealing at 58°C for 90 sec
•Extension at 72°C for 60 sec
•5-min extension at 72°C
H&E Staining
Lung tissues were fixed in 10% buffered formalin,
embedded in paraffin and cut into 5-µm sections.
Sections were deparaffinized and stained with
hematoxylin and eosin (H&E).
Methods
Ccsp-Cre;LSL-K-ras G12D;Scgb3a2 single floxed (+/f)
Lung Tumors in 6-month-old
male oncogenic K-ras mice
*Blue arrows indicate lung tumors
Ccsp-Cre;LSL-K-ras G12D;Scgb3a2 double floxed (f/f)
Acknowledgments
• Yan Cai
• Manabu Iwadate
• Shuko Kawabe
• Tsubasa Murata
• Lei Xu
X40
Ccsp-Cre;LSL-K-ras G12D;
Scgb3a2 single floxed (+/f)
Ccsp-Cre;LSL-K-ras G12D;
Scgb3a2 double floxed (f/f)
C; Cancerous tissue
Normal
X400 X400
X40 X40
X400
c
c
c
Survival Curve - Male
Results
p value = 0.035
Immunohistochemistry
Ccsp-Cre;LSL-K-ras G12D;
Scgb3a2 single floxed (+/f)
Ccsp-Cre;LSL-K-ras G12D;
Scgb3a2 double floxed (f/f)
*Brown indicates the expression of SCGB3A2.
Ccsp-Cre;LSL-K-ras G12D;
Wild Type
c
•SCGB3A2 was not
expressed in Ccsp-
Cre;LSL-K-ras G12D;
Scgb3a2 double floxed
(f/f).
c c
• Shigetoshi Yokoyama
• NIH Summer Intern
Program
H&E Staining of adenocarcinomas in
oncogenic K-ras lungs
C; Cancerous tissue

More Related Content

What's hot

Tissue Culture and Cloning Work
Tissue Culture and Cloning WorkTissue Culture and Cloning Work
Tissue Culture and Cloning WorkSatrupa Das
 
CRISPR, a New Genome editor agent
CRISPR, a New Genome editor agentCRISPR, a New Genome editor agent
CRISPR, a New Genome editor agentAli Ahmadi
 
Targeted T-cell receptor beta immune repertoire sequencing in several FFPE ti...
Targeted T-cell receptor beta immune repertoire sequencing in several FFPE ti...Targeted T-cell receptor beta immune repertoire sequencing in several FFPE ti...
Targeted T-cell receptor beta immune repertoire sequencing in several FFPE ti...Thermo Fisher Scientific
 
the application of CRISPR/Cas9 system in genome editing
the application of CRISPR/Cas9 system in genome editingthe application of CRISPR/Cas9 system in genome editing
the application of CRISPR/Cas9 system in genome editingArash zolnori
 
Chemically ligated gRNAs for CRISPR applications.
Chemically ligated gRNAs for CRISPR applications.Chemically ligated gRNAs for CRISPR applications.
Chemically ligated gRNAs for CRISPR applications.Minghong Zhong
 
Gene Editing for everyone
Gene Editing for everyoneGene Editing for everyone
Gene Editing for everyoneMike Jowett
 
CRISPR Based Diagnosis For SARS-CoV-2[FELUDA]
CRISPR Based Diagnosis For SARS-CoV-2[FELUDA]CRISPR Based Diagnosis For SARS-CoV-2[FELUDA]
CRISPR Based Diagnosis For SARS-CoV-2[FELUDA]Barun Kumar Sahu
 
Restriction enzymes (mc qs)
Restriction enzymes (mc qs)Restriction enzymes (mc qs)
Restriction enzymes (mc qs)Harshraj Shinde
 
Institute of Learning in Retirement - Miami University (Ohio)
Institute of Learning in Retirement - Miami University (Ohio)Institute of Learning in Retirement - Miami University (Ohio)
Institute of Learning in Retirement - Miami University (Ohio)Andor Kiss
 
Moleculer basis of inheritance (1)
Moleculer basis of inheritance (1)Moleculer basis of inheritance (1)
Moleculer basis of inheritance (1)nivedhithav2
 
Worm timing paper
Worm timing paperWorm timing paper
Worm timing paperArjun Raj
 

What's hot (20)

Duke neuro 1.10
Duke neuro 1.10Duke neuro 1.10
Duke neuro 1.10
 
NCSU Poster
NCSU PosterNCSU Poster
NCSU Poster
 
NiH_Presentation
NiH_PresentationNiH_Presentation
NiH_Presentation
 
Tissue Culture and Cloning Work
Tissue Culture and Cloning WorkTissue Culture and Cloning Work
Tissue Culture and Cloning Work
 
CRISPR, a New Genome editor agent
CRISPR, a New Genome editor agentCRISPR, a New Genome editor agent
CRISPR, a New Genome editor agent
 
Short hairpin rna
Short hairpin rnaShort hairpin rna
Short hairpin rna
 
Crispr trap
Crispr trapCrispr trap
Crispr trap
 
Targeted T-cell receptor beta immune repertoire sequencing in several FFPE ti...
Targeted T-cell receptor beta immune repertoire sequencing in several FFPE ti...Targeted T-cell receptor beta immune repertoire sequencing in several FFPE ti...
Targeted T-cell receptor beta immune repertoire sequencing in several FFPE ti...
 
the application of CRISPR/Cas9 system in genome editing
the application of CRISPR/Cas9 system in genome editingthe application of CRISPR/Cas9 system in genome editing
the application of CRISPR/Cas9 system in genome editing
 
Kira's poster Final
Kira's poster FinalKira's poster Final
Kira's poster Final
 
Chemically ligated gRNAs for CRISPR applications.
Chemically ligated gRNAs for CRISPR applications.Chemically ligated gRNAs for CRISPR applications.
Chemically ligated gRNAs for CRISPR applications.
 
GKA deel 1 college 4
GKA deel 1 college 4GKA deel 1 college 4
GKA deel 1 college 4
 
Gene Editing for everyone
Gene Editing for everyoneGene Editing for everyone
Gene Editing for everyone
 
CRISPR Based Diagnosis For SARS-CoV-2[FELUDA]
CRISPR Based Diagnosis For SARS-CoV-2[FELUDA]CRISPR Based Diagnosis For SARS-CoV-2[FELUDA]
CRISPR Based Diagnosis For SARS-CoV-2[FELUDA]
 
Restriction enzymes (mc qs)
Restriction enzymes (mc qs)Restriction enzymes (mc qs)
Restriction enzymes (mc qs)
 
Institute of Learning in Retirement - Miami University (Ohio)
Institute of Learning in Retirement - Miami University (Ohio)Institute of Learning in Retirement - Miami University (Ohio)
Institute of Learning in Retirement - Miami University (Ohio)
 
RIP 24Feb2016v4
RIP 24Feb2016v4RIP 24Feb2016v4
RIP 24Feb2016v4
 
Moleculer basis of inheritance (1)
Moleculer basis of inheritance (1)Moleculer basis of inheritance (1)
Moleculer basis of inheritance (1)
 
Crispr cas
Crispr casCrispr cas
Crispr cas
 
Worm timing paper
Worm timing paperWorm timing paper
Worm timing paper
 

Similar to SCGB3A2 Suppresses K-ras-Induced Lung Cancer in Mice

Purification, Peptide Sequencing and Study of Antiproliferative activity of L...
Purification, Peptide Sequencing and Study of Antiproliferative activity of L...Purification, Peptide Sequencing and Study of Antiproliferative activity of L...
Purification, Peptide Sequencing and Study of Antiproliferative activity of L...Dr. Antik Bose
 
Making genome edits in mammalian cells
Making genome edits in mammalian cellsMaking genome edits in mammalian cells
Making genome edits in mammalian cellsChris Thorne
 
CRISPR-Cas: for crop improvement
CRISPR-Cas: for crop improvementCRISPR-Cas: for crop improvement
CRISPR-Cas: for crop improvementSajid Sheikh
 
RNA splicing mutations and human disease: Pompe disease.
RNA splicing mutations and human disease: Pompe disease.RNA splicing mutations and human disease: Pompe disease.
RNA splicing mutations and human disease: Pompe disease.CentroMalattieRareFVG
 
Lessons learned from high throughput CRISPR targeting in human cell lines
Lessons learned from high throughput CRISPR targeting in human cell linesLessons learned from high throughput CRISPR targeting in human cell lines
Lessons learned from high throughput CRISPR targeting in human cell linesChris Thorne
 
Western Blotting Of Camkii Β And T 287
Western Blotting Of Camkii Β And T 287Western Blotting Of Camkii Β And T 287
Western Blotting Of Camkii Β And T 287Beth Salazar
 
A reading report for <A Secreted Slit2 Fragment Regulates Adipose Tissue Ther...
A reading report for <A Secreted Slit2 Fragment Regulates Adipose Tissue Ther...A reading report for <A Secreted Slit2 Fragment Regulates Adipose Tissue Ther...
A reading report for <A Secreted Slit2 Fragment Regulates Adipose Tissue Ther...星云 王
 
Fluorescence activated cell sorted assay for Gaucher's disease
Fluorescence activated cell sorted assay for Gaucher's diseaseFluorescence activated cell sorted assay for Gaucher's disease
Fluorescence activated cell sorted assay for Gaucher's diseaseMayank Sagar
 
Honours Report Draft COMPLETE
Honours Report Draft COMPLETEHonours Report Draft COMPLETE
Honours Report Draft COMPLETEBjorn Hunter
 
immunohistochemically and in situ hybridizati.pptx
immunohistochemically and in situ hybridizati.pptximmunohistochemically and in situ hybridizati.pptx
immunohistochemically and in situ hybridizati.pptxMarwa972783
 
immunohistochemically and in situ hybridizati.pptx
immunohistochemically and in situ hybridizati.pptximmunohistochemically and in situ hybridizati.pptx
immunohistochemically and in situ hybridizati.pptxMarwa972783
 
Medicilon KRAS-targeted Drugs R&D Service.pdf
Medicilon KRAS-targeted Drugs R&D Service.pdfMedicilon KRAS-targeted Drugs R&D Service.pdf
Medicilon KRAS-targeted Drugs R&D Service.pdfmedicilonz
 
Generation of MRP2 Efflux Transporter Knock-Out in HepaRG Cell Line
Generation of MRP2 Efflux Transporter Knock-Out in HepaRG Cell LineGeneration of MRP2 Efflux Transporter Knock-Out in HepaRG Cell Line
Generation of MRP2 Efflux Transporter Knock-Out in HepaRG Cell Linemdmitc
 

Similar to SCGB3A2 Suppresses K-ras-Induced Lung Cancer in Mice (20)

Paloma Pérez-Enfermedades raras de la piel
Paloma Pérez-Enfermedades raras de la pielPaloma Pérez-Enfermedades raras de la piel
Paloma Pérez-Enfermedades raras de la piel
 
Purification, Peptide Sequencing and Study of Antiproliferative activity of L...
Purification, Peptide Sequencing and Study of Antiproliferative activity of L...Purification, Peptide Sequencing and Study of Antiproliferative activity of L...
Purification, Peptide Sequencing and Study of Antiproliferative activity of L...
 
Making genome edits in mammalian cells
Making genome edits in mammalian cellsMaking genome edits in mammalian cells
Making genome edits in mammalian cells
 
CRISPR-Cas: for crop improvement
CRISPR-Cas: for crop improvementCRISPR-Cas: for crop improvement
CRISPR-Cas: for crop improvement
 
2013_WCBSURC.pptx
2013_WCBSURC.pptx2013_WCBSURC.pptx
2013_WCBSURC.pptx
 
Dna sequencing
Dna sequencingDna sequencing
Dna sequencing
 
RNA splicing mutations and human disease: Pompe disease.
RNA splicing mutations and human disease: Pompe disease.RNA splicing mutations and human disease: Pompe disease.
RNA splicing mutations and human disease: Pompe disease.
 
Lessons learned from high throughput CRISPR targeting in human cell lines
Lessons learned from high throughput CRISPR targeting in human cell linesLessons learned from high throughput CRISPR targeting in human cell lines
Lessons learned from high throughput CRISPR targeting in human cell lines
 
Western Blotting Of Camkii Β And T 287
Western Blotting Of Camkii Β And T 287Western Blotting Of Camkii Β And T 287
Western Blotting Of Camkii Β And T 287
 
A reading report for <A Secreted Slit2 Fragment Regulates Adipose Tissue Ther...
A reading report for <A Secreted Slit2 Fragment Regulates Adipose Tissue Ther...A reading report for <A Secreted Slit2 Fragment Regulates Adipose Tissue Ther...
A reading report for <A Secreted Slit2 Fragment Regulates Adipose Tissue Ther...
 
publication 4
publication 4publication 4
publication 4
 
Fluorescence activated cell sorted assay for Gaucher's disease
Fluorescence activated cell sorted assay for Gaucher's diseaseFluorescence activated cell sorted assay for Gaucher's disease
Fluorescence activated cell sorted assay for Gaucher's disease
 
Honours Report Draft COMPLETE
Honours Report Draft COMPLETEHonours Report Draft COMPLETE
Honours Report Draft COMPLETE
 
PfGDH.pptx
PfGDH.pptxPfGDH.pptx
PfGDH.pptx
 
Fall project
Fall projectFall project
Fall project
 
immunohistochemically and in situ hybridizati.pptx
immunohistochemically and in situ hybridizati.pptximmunohistochemically and in situ hybridizati.pptx
immunohistochemically and in situ hybridizati.pptx
 
immunohistochemically and in situ hybridizati.pptx
immunohistochemically and in situ hybridizati.pptximmunohistochemically and in situ hybridizati.pptx
immunohistochemically and in situ hybridizati.pptx
 
Medicilon KRAS-targeted Drugs R&D Service.pdf
Medicilon KRAS-targeted Drugs R&D Service.pdfMedicilon KRAS-targeted Drugs R&D Service.pdf
Medicilon KRAS-targeted Drugs R&D Service.pdf
 
Generation of MRP2 Efflux Transporter Knock-Out in HepaRG Cell Line
Generation of MRP2 Efflux Transporter Knock-Out in HepaRG Cell LineGeneration of MRP2 Efflux Transporter Knock-Out in HepaRG Cell Line
Generation of MRP2 Efflux Transporter Knock-Out in HepaRG Cell Line
 
Making the TRK to Precision Medicine in Cancer: The Promise of Targeting TRK ...
Making the TRK to Precision Medicine in Cancer: The Promise of Targeting TRK ...Making the TRK to Precision Medicine in Cancer: The Promise of Targeting TRK ...
Making the TRK to Precision Medicine in Cancer: The Promise of Targeting TRK ...
 

SCGB3A2 Suppresses K-ras-Induced Lung Cancer in Mice

  • 1. 21 BackgroundAbstract Secretoglobin (SCGB) 3A2, formerly called Uteroglobin-related protein (UGRP) 1, was originally identified as a downstream target for a homeodomain transcription factor, NKX2-1. SCGB3A2 is highly expressed in the epithelial cells of the trachea, bronchus and bronchioles. SCGB3A2 exhibits anti-inflammatory and anti- fibrotic functions as well as growth factor activity that is responsible for fetal lung development. Our recent study demonstrated that SCGB3A2 is over-expressed in lung carcinomas, particularly adenocarcinomas in humans. In order to further understand the physiological roles of SCGB3A2 in lungs and/or lung diseases including lung cancer, we have produced Scgb3a2 knockout mice. These knockout mice are characterized to identify additional roles for SCGB3A2 in lungs. Our purpose of this study is to understand the biological function and molecular mechanism of SCGB3A2 in a mouse model of oncogenic K-ras- induced lung cancer. Ccsp-Cre/LSL-K-rasG12D knock-in mouse mated with floxed Scgb3a2 mouse Compare the phenotypes of Scgb3a2 (+/flox) to Scgb3a2 (flox/flox) in oncogenic K-ras mice Future Experiments • To obtain pathological analysis for the classification of cancer severity. • To extend the observational time in order to obtain a more accurate survival curve and increase the sample size of +/fl and fl/fl mice for lung weight data. • Prepare mouse embryonic (MEF) and primary lung fibroblasts from mice carrying K-rasG12D in the background of Scgb3a2(-/-) or wild type, and treat them with recombinant adenovirus expressing Cre recombinase (Ad-Cre) to study the mechanism for the role of SCGB3A2 in carcinogenesis. Summary • Floxed, transgenic and knock-in alleles were identified by PCR. • Oncogenic K-ras induced lung cancers were developed in Scgb3a2 (+/flox), Scgb3a2 (flox/flox) and wild type mice. • Scgb3a2 (flox/flox) displays a shortened life span compared with Scgb3a2 (+/flox) in oncogenic K-ras- induced lung carcinogenesis. • Gross tumor number, body weight, tumor size, and lung weight had no significant difference between Scgb3a2 (+/flox) and Scgb3a2 (flox/flox) mice. • SCGB3A2 might inhibit oncogenic K- ras-induced lung carcinogenesis. Genotype PCR 650 400 200 WT +/f f/f 300 500 WT (411 bp) Floxed (354 bp) - - + + 550 bp 400 500 650 850 1000 408 bp 400 500 300 - - + + Floxed Scgb3a2 Ccsp-Cre K-ras G12D (Oncogenic K-ras) LSL-K-rasG12D knock-in allele Floxed Scgb3a2X WT K-ras allele Activated K-rasG12D allele Ccsp-Cre;LSL-K-ras G12D Effect of the loss of SCGB3A2 on oncogenic K-ras-induced lung carcinogenesis in mice Angela Zhou, Mitsuhiro Yoneda, Jorge Paiz, and Shioko Kimura Endocrinology Section, Laboratory of Metabolism, Center for Cancer Research, NCI, NIH, Bethesda, MD 20892, USA SCGB3A2 suppresses K-ras-induced carcinogenesis in mice lungs. Ccsp-Cre;LSL-K-ras G12D;Scgb3a2 single floxed (+/f) Ccsp-Cre;LSL-K-ras G12D;Scgb3a2 double floxed (f/f) Expected incidence of lung cancer Hypothesis Mice Ccsp-Cre;LSL-K-rasG12D;Scgb3a2(f/f) and Ccsp- Cre;LSL-K-rasG12D;Scgb3a2(+/f) mice are used in this study. Ccsp-Cre/LSL-K-rasG12D conditional mutant mice were kindly provided from Dr. DeMayo (Baylor College of Medicine). Floxed-Scgb3a2 mice were produced in our laboratory. All mice were maintained under standard specific-pathogen-free conditions. All experiments were carried out following guidelines for animal use issued by the National Institutes of Health and approved by the National Cancer Institute (NCI) Animal Care and Use Committee. Genotyping for conditional mutant mice Floxed, transgenic and knock-in mice were identified using PCR primers specific for each transgene. Amplification of PCR products for floxed and Cre transgenic mice were performed as follows: •Denaturation at 94°C for 5 min •38 cycles of: •Denaturation at 94°C for 15 sec •Annealing at 60°C for 30 sec •Extension at 72°C for 15 sec •5-min extension at 72°C Amplification for the LSL-K-rasG12D knock-in allele was performed as follows: •Denaturation at 94°C for 3 min •40 cycles of: •Denaturation at 94°C for 30 sec •Annealing at 58°C for 90 sec •Extension at 72°C for 60 sec •5-min extension at 72°C H&E Staining Lung tissues were fixed in 10% buffered formalin, embedded in paraffin and cut into 5-µm sections. Sections were deparaffinized and stained with hematoxylin and eosin (H&E). Methods Ccsp-Cre;LSL-K-ras G12D;Scgb3a2 single floxed (+/f) Lung Tumors in 6-month-old male oncogenic K-ras mice *Blue arrows indicate lung tumors Ccsp-Cre;LSL-K-ras G12D;Scgb3a2 double floxed (f/f) Acknowledgments • Yan Cai • Manabu Iwadate • Shuko Kawabe • Tsubasa Murata • Lei Xu X40 Ccsp-Cre;LSL-K-ras G12D; Scgb3a2 single floxed (+/f) Ccsp-Cre;LSL-K-ras G12D; Scgb3a2 double floxed (f/f) C; Cancerous tissue Normal X400 X400 X40 X40 X400 c c c Survival Curve - Male Results p value = 0.035 Immunohistochemistry Ccsp-Cre;LSL-K-ras G12D; Scgb3a2 single floxed (+/f) Ccsp-Cre;LSL-K-ras G12D; Scgb3a2 double floxed (f/f) *Brown indicates the expression of SCGB3A2. Ccsp-Cre;LSL-K-ras G12D; Wild Type c •SCGB3A2 was not expressed in Ccsp- Cre;LSL-K-ras G12D; Scgb3a2 double floxed (f/f). c c • Shigetoshi Yokoyama • NIH Summer Intern Program H&E Staining of adenocarcinomas in oncogenic K-ras lungs C; Cancerous tissue

Editor's Notes

  1. Ccsp Promoter– cre : cre promoter (activator) expressed in bronchial epithelial cells G12D – amino acid mutation Confirmed by using rosa. Expressing region (visual) with rosa